Homepage688235 • SHA
add
Beigene Ltd
Vorige slotkoers
¥ 230,20
Dag-range
¥ 214,55 - ¥ 231,37
Jaar-range
¥ 111,22 - ¥ 248,00
Beurswaarde
185,35 mld. CNY
Gem. volume
2,32 mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
SHA
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 1,19 mld. | 84,84% |
Bedrijfskosten | 1,09 mld. | 19,51% |
Netto inkomsten | -139,70 mln. | 58,27% |
Netto winstmarge | -11,75 | 77,43% |
Winst per aandeel | -0,80 | -196,59% |
EBITDA | -33,25 mln. | 90,73% |
Effectief belastingtarief | -112,84% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,63 mld. | -17,16% |
Totale activa | 5,92 mld. | 1,99% |
Totale passiva | 2,59 mld. | 14,14% |
Totaal aandelenvermogen | 3,33 mld. | — |
Uitstaande aandelen | 106,72 mln. | — |
Koers-boekwaardeverhouding | 7,37 | — |
Rendement op activa | -3,26% | — |
Rendement op kapitaal | -4,29% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2024info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -139,70 mln. | 58,27% |
Operationele kasstroom | 111,61 mln. | 128,21% |
Kasstroom uit beleggingen | -247,31 mln. | 26,86% |
Kasstroom uit financiering | 30,05 mln. | -92,11% |
Nettomutatie in liquide middelen | -155,64 mln. | 57,59% |
Vrije kasstroom | 434,97 mln. | 505,95% |
Over
BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in the Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November, 2024 the company announced its intention to rebrand as BeOne Medicines. Wikipedia
Opgericht
28 okt 2010
Website
Werknemers
11.000
